Sars-Cov-2 Recombinant Spike Protein

Records for this ingredient, by country (identity only).

ATC J07BN04 · 2 markets · 6 records

Sars-Cov-2 Recombinant Spike Protein 2 markets · 6 records Forms
Filters
MarketSG 3CA 1

SG 3 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 5 mcg/dose per mL / per unit basis not statedinjectionNUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDVNUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)
  • 0.005 mg/0.5 mLinjectionNuvaxovid Dispersion for Injection COVID19 Vaccine 5mcg/dose (recombinant, adjuvanted) in PFS

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 0.005 mg per mL / per unit basis not statedliquidNUVAXOVID

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.